全球糖尿病視網膜病變市場規模、佔有率、成長分析，依類型（增殖性糖尿病視網膜病變和非增殖性糖尿病視網膜病變），依管理（抗 VEGF、眼內類固醇注射） - 行業預測 2024-2031

Global Diabetic Retinopathy Market Size, Share, Growth Analysis, By Type(Proliferative Diabetic Retinopathy, and Non-proliferative diabetic retinopathy), By Management(Anti-VEGF, Intraocular Steroid Injection) - Industry Forecast 2024-2031

出版日期: 2024年03月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球糖尿病視網膜病變市場規模為83.0億美元，預計將從2023年的88.3億美元成長到2031年的145.1億美元，在預測期內（2024-2031年）複合年成長率為6.4%。

市場擴張預計將受到多種因素的推動，包括糖尿病發病率上升、人口老化以及與糖尿病相關的失明率上升。此外，人們對糖尿病認知的提高和新產品的推出也促進了市場的成長。糖尿病是一種普遍存在的全球性疾病，其特徵是胰臟無法產生胰島素，導致血糖水平升高並損害視網膜毛細血管，從而導致糖尿病性視網膜病變。高血糖水平和監測不足被認為是視網膜變性的危險因素，但早期發現糖尿病、適當用藥、使用現代工具持續自我監測以及採用健康的生活方式可以減輕視網膜損傷並降低糖尿病視網膜病變的發病率。儘管採取了預防措施，糖尿病視網膜病變仍可能導致不可逆轉的失明，因此需要早期檢測策略，例如 Check Eye 提供的策略，這是一家利用人工智慧篩檢糖尿病視網膜病變的健康科技公司。在英國，糖尿病視網膜病變是導致失明的主要原因之一，凸顯了消費者意識和增加醫療保健支出的重要性。此外，預計到 2050 年，全球老齡化人口將增加兩倍，維持健康的生活方式和定期監測血糖對於降低糖尿病及其併發症的風險至關重要。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Novartis AG
Roche Holding AG
Bayer AG
Regeneron Pharmaceuticals, Inc.
Allergan plc (AbbVie Inc.)
Carl Zeiss Meditec AG
Topcon Corporation
Nidek Co., Ltd.
Optos plc (Nikon Corporation)
Bausch Health Companies Inc.
Alcon Inc.
Santen Pharmaceutical Co., Ltd.
Lumenis Ltd. (XIO Group)
Iridex Corporation
Leica Microsystems (Danaher Corporation)
StemCells Inc. (Microbot Medical Inc.)
Bioptigen, Inc. (Metabolic Technologies Inc.)
CenterVue SpA
Visunex Medical Systems, Inc.
Clarity Medical Systems, Inc.

簡介目錄

Product Code: SQMIG35A2516

Global Diabetic Retinopathy Market size was valued at USD 8.30 billion in 2022 and is poised to grow from USD 8.83 billion in 2023 to USD 14.51 billion by 2031, growing at a CAGR of 6.4% during the forecast period (2024-2031).

The market expansion is expected to be propelled by several factors including the increasing incidence of diabetes, a growing aging population, and the rise in diabetes-related blindness. Additionally, heightened awareness of diabetes and the introduction of new products are contributing to market growth. Diabetes, a prevalent global condition characterized by the pancreas' inability to produce insulin, leads to elevated blood sugar levels and damage to retinal blood capillaries, resulting in diabetic retinopathy. High blood sugar levels and inadequate monitoring are considered risk factors for retinal degeneration, but early detection of diabetes, proper medication, continuous self-monitoring using modern tools, and embracing a healthy lifestyle can mitigate retinal damage and lower the incidence of diabetic retinopathy. Despite preventive efforts, diabetic retinopathy can lead to irreversible blindness, necessitating early detection strategies like those offered by Check Eye, a healthtech company leveraging AI to screen for diabetic retinopathy. In the UK, diabetic retinopathy ranks among the leading causes of blindness, underscoring the importance of consumer awareness and increased healthcare spending. Moreover, with the global aging population projected to triple by 2050, maintaining a healthy lifestyle and regular blood glucose monitoring are imperative to mitigate the risks associated with diabetes and its complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetic Retinopathy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetic Retinopathy Market Segmental Analysis

The global diabetic retinopathy market is segmented based on type, management, and region. Based on type, the market is segmented into proliferative diabetic retinopathy, and non-proliferative diabetic retinopathy. With respect to categorization by management, the market is segmented into anti-VEGF, intraocular steroid injection, laser surgery, vitrectomy. Regionwise, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Diabetic Retinopathy Market

The diabetic retinopathy market is witnessing significant expansion, propelled by augmented investments in healthcare infrastructure, which foster improved healthcare provision and accessibility. Concurrently, concerted endeavors by public and private entities to boost awareness regarding diabetic retinopathy are bolstering market growth. Furthermore, favorable reimbursement conditions and a populace with substantial disposable income are fostering the market's expansion. The demographic shift towards an aging population, coupled with evolving lifestyles, further accelerates the market's growth trajectory.

Restraints in the Global Diabetic Retinopathy Market

The increasing occurrence of diabetic retinopathy is accompanied by insufficient awareness regarding the condition and the necessity of regular eye check-ups among individuals with diabetes. Restricted availability of eye care services, especially in remote or underserved regions, poses obstacles to early detection and prompt intervention.

Market Trends of the Global Diabetic Retinopathy Market

Increasingly acknowledged is the pivotal role of early detection and intervention in addressing diabetic retinopathy, with emphasis shifting towards implementing routine screening initiatives, raising awareness through campaigns, and adopting cutting-edge imaging techniques to facilitate prompt diagnosis, thereby enabling timely therapeutic interventions and more effective disease management.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Diabetic Retinopathy Market by Type

Market Overview
Proliferative Diabetic Retinopathy
and Non-proliferative diabetic retinopathy

Global Diabetic Retinopathy Market by Management

Market Overview
Anti-VEGF
Intraocular Steroid Injection
Laser Surgery
and Vitrectomy

Global Diabetic Retinopathy Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regeneron Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc (AbbVie Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss Meditec AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Topcon Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nidek Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optos plc (Nikon Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch Health Companies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Santen Pharmaceutical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lumenis Ltd. (XIO Group)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Iridex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leica Microsystems (Danaher Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
StemCells Inc. (Microbot Medical Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioptigen, Inc. (Metabolic Technologies Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CenterVue SpA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Visunex Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clarity Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments